Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
We argue here that in many ways, Ewing sarcoma (EwS) is a unique tumor entity and yet, it shares many commonalities with other immunologically cold solid malignancies. From the historical perspective, EwS, osteosarcoma (OS) and other bone and soft-tissue sarcomas were the first types of tumors treat...
Main Authors: | Valentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi, Stefan E. G. Burdach |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/1/272 |
Similar Items
-
Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
by: Manideep C. Pachva, et al.
Published: (2021-09-01) -
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function
by: Hendrik Gassmann, et al.
Published: (2021-08-01) -
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
by: Stefania Kokkali, et al.
Published: (2023-01-01) -
Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review
by: Robert Koucheki, et al.
Published: (2021-09-01) -
A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis
by: Jinkui Wang, et al.
Published: (2022-02-01)